GoodRx(GDRX) - 2023 Q3 - Earnings Call Presentation

Scale our pharma manufacturer solutions efforts Scott Wagner Interim CEO Meaningful progress made against top priorities in Q3 1 2 3 4 Make sure we have the strongest network relationships and retail pharmacy strategy possible Hone our short- and medium-term growth plans for the core prescription transactions offering and align our teams and resources behind it November 9, 2023 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litig ...